Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1993-12-16
pubmed:abstractText
Twenty-two cases of basal-cell carcinoma (BCC) and 21 cases of squamous-cell carcinoma of the skin (SCC) were stained for Ber EP4 using indirect immunofluorescence and avidin-biotin-peroxidase techniques. The results showed that all BCCs were diffusely and intensely labeled, whereas none of the SCCs expressed Ber EP4, irrespective of their histological type or grade of differentiation. This difference may prove useful in (a) histologically differentiating between these two neoplasms; and (b) in clarifying the histogenesis of neoplasms considered to be intermediate between BCC and SCC, or derived from BCC. In addition, because significant differences between the staining of hair follicles and BCC were noted, evaluation for Ber EP4 expression could assist in distinguishing between BCC and hair follicles in Mohs micrographic sections.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0193-1091
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
452-5
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin.
pubmed:affiliation
Clinica de Dermatologia, Hospital da Universidade de Coimbra, Portugal.
pubmed:publicationType
Journal Article